Health Care/Hospital

Noah Launches "Play The Full Game" Campaign with Singaporean Football Legend Fandi Ahmad as Brand Ambassador

SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- Noah, the telehealth platform tailored for men and created by Ordinary Folk, is pleased to announce the launch of its "Play The Full Game" campaign and the appointment ofFandi Ahmad as Noah's brand ambassador. The campaign aims to empower men to have the co...

2023-11-09 14:31 1835

West Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets

SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Nilesh Shah to serve as Vice President and General Manager of Emerging Mark...

2023-11-09 12:58 9015

European Wellness and DXN Sign MoU to Establish World-Class Wellness Centre!

CYBERJAYA, Malaysia, Nov. 9, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group) has signed a Memorandum of Understanding with DXN Holdings Berhad (DXN) to jointly develop and establish a comprehensive wellness centre that draws from the extensive expertise and experience of both p...

2023-11-09 11:46 2190

Next New World announces shelf-life extension validation for delicate fruits and vegetables

SINGAPORE, Nov. 9, 2023 /PRNewswire/ -- Next New World Pte. Ltd., in collaboration with The Food Innovation and Resource Centre (FIRC), have validated the shelf-life extension of delicate fruits and vegetables (Bananas and Avocados) by an average of 1.5 times. This feat has been made possible th...

2023-11-09 10:02 1765

DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells

Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Nov. 9, 2023 /PRNewswire/ -- DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function...

2023-11-09 08:15 1663

Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023

HANGZHOU and SHAOXING, China, Nov. 9, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that Dr.Jinzi J. Wu, Founder, Chairman and CEO of Ascletis was invited to attend and have a presentation at the 10th International Workshop on HBV Cure 2023 held atBoston, Unit...

2023-11-09 08:10 4130

Telix to Present at Jefferies London Healthcare Conference 2023

MELBOURNE, Australia, Nov. 9, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies London Healthcare Conference 2023. The presentation will take place o...

2023-11-09 04:51 1544

Frost & Sullivan Honors Leading Organizations with Prestigious Industry Awards at the 2023 Best Practices Awards Ceremony

Sixteen Companies Awarded Excellence in Best Practices by Frost & Sullivan for Best-in-Class Performance KUALA LUMPUR, Malaysia, Nov. 9, 2023 /PRNewswire/ -- The 2023 Frost & Sullivan Best Practices Awards Ceremony took place at the St. Regis Hotel in Kuala Lumpur, Malaysia, bringing together com...

2023-11-09 00:08 1723

Allgenesis Announces Encouraging Preliminary Safety and Efficacy Data from the AG-73305 Phase 2a Trial for the Treatment of Diabetic Macular Edema at American Academy of Ophthalmology

TAIPEI, Nov. 8, 2023 /PRNewswire/ --  * AG-73305 was found to be safe and tolerable with no severe adverse effects (SAEs) after a single intravitreal injection of doses of 0.5, 1, 2, and 4 mg in DME patients. * Data combining all 4 cohorts showed mean improvement in Best Corrected Visual Acc...

2023-11-08 23:23 1746

Seoul National University Bundang Hospital (SNUBH) Secures Prestigious GHA Accreditation, Reinforcing Its Position as a Premier Global Medical Travel Destination

PALM BEACH GARDENS, Fla., Nov. 8, 2023 /PRNewswire/ -- Seoul National University Bundang Hospital (SNUBH), one of South Korea's most prestigious healthcare institutions, is delighted to announce that it has achieved a second consecutive term of Accreditation with Excellence fromGlobal Healthcare ...

2023-11-08 19:00 1574

The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit Delivered Insights on the Future of Healthcare

SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit (AHLSICS), hosted by ASK Health Asia and the SingHealth Duke-NUS Global Health Institute (SDGHI), in collaboration with the World Economic Forum, successfully concluded in Singapore on 1s...

2023-11-08 14:30 2221

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

MELBOURNE, Australia, Nov. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed an exclusive agreement withDenmark-based WIIK Pharma ApS (Wiik Pharma) for the distribution of Telix's investigational prostate cancer imaging agent, Illuc...

2023-11-08 13:00 1433

Simulare Medical Launches the Alveolar Bone Graft Simulator

ABG Simulator New Addition to Further Support Cleft Reconstructive Surgical Training TAIPEI, Nov. 8, 2023 /PRNewswire/ -- Simulare Medical, a division of Smile Train Inc. (New York) announces the launch of the Alveolar Bone Graft (ABG) simulator, the latest high-fidelity surgical item in its gro...

2023-11-08 10:00 1860

Docquity Expands Digitized Patient Access Programs To Enhance Healthcare Outcomes in Thailand

* After a successful pilot in the Philippines, five DocquityCare Patient Access Programs (PAPs)have been launched in Thailand * DocquityCare PAP will support more than 100 hospitals and 250 healthcare professionals (HCPs) to improve patient care for those with cancer and other life-threatenin...

2023-11-08 10:00 1714

Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs

* During the event, Antengene will review promising data of its R&D pipeline, includingATG-031 (anti-CD24 monoclonal antibody), ATG-101 (PD-L1/4-1BB bispecific antibody), ATG-022 (Claudin 18.2 antibody-drug conjugate), ATG-037 (CD73 inhibitor), and ATG-008 (dual mTORC1/2 inhibitor). * The vir...

2023-11-08 08:30 1594

Flagship Pioneering Expands into Asia-Pacific Region, with Regional Hub in Singapore

André Andonian Joins Flagship to Lead APAC Region SINGAPORE, Nov. 8, 2023 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced its expansion into theAsia-Pacific region, with the opening of a regional hub inSingapore. This follows the company's expansion into ...

2023-11-08 06:00 1583

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

* ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years. * ESR1 mutations are present in up to 40% of ER+, HER2- advance...

2023-11-08 02:01 1478

Discovery Life Sciences Announces New CEO

Greg Herrema to Spearhead Next Phase of Global Biospecimen and Biomarker Company's Expansion HUNTSVILLE, Ala., Nov. 7, 2023 /PRNewswire/ -- Discovery Life Sciences, the Biospecimen and Biomarker Specialists, announced today the appointment ofGreg Herrema as its new chief executive officer. A lea...

2023-11-07 23:01 1655

Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs

* Company's eTurna™ delivery platform ensures unprecedented precision, safety * In-vivo biodistribution of mRNA into dermal cells, tissues shows high transfection efficiency, gene expression * Data presented at ASDS Annual Meeting MOUNTAIN VIEW, Calif., Nov. 7, 2023 /PRNewswire/ -- Turn Biot...

2023-11-07 21:30 2282

Registration for the 7th IFPA Conference 2024 now open

STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- IFPA (International Federation of Psoriasis Associations) is thrilled to announce the 7th IFPA Conference (former World Psoriasis & Psoriatic Arthritis Conference), set to take place fromJune 27 to 29, 2024, in the vibrant city of Stockholm, Sweden. Establi...

2023-11-07 18:00 1527
1 ... 43444546474849 ... 554